Matthew K Armstrong1, Brooklyn J Fraser1, Olli Hartiala2,3, Marie-Jeanne Buscot1, Markus Juonala4,5, Feitong Wu1, Juha Koskinen6, Nina Hutri-Kähönen7, Mika Kähönen8, Tomi P Laitinen9, Terho Lehtimäki10, Jorma S A Viikari4,5, Olli T Raitakari2,3,11, Costan G Magnussen1,2,3. 1. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. 2. Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. 3. Centre for Population Health Research, Turku University Hospital, University of Turku, Turku, Finland. 4. Department of Medicine, University of Turku, Turku, Finland. 5. Division of Medicine, Turku University Hospital, Turku, Finland. 6. Heart Center, Kymenlaakso Central Hospital, Kotka, Finland. 7. Tampere University Hospital, Department of Pediatrics, Tampere University, Tampere, Finland. 8. Tampere University Hospital, Department of Clinical Physiology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. 9. Kuopio University Hospital, Department of Clinical Physiology and Nuclear Medicine, University of Eastern Finland, Kuopio, Finland. 10. Department of Clinical Chemistry, Fimlab Laboratories and Faculty of Medicine and Health Technology, Finnish Cardiovascular Research Center-Tampere, Tampere University, Tampere, Finland. 11. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
Abstract
Importance: Elevated non-high-density lipoprotein cholesterol (non-HDL-C) is associated with the presence of coronary artery calcification (CAC), a marker of heart disease in adulthood. However, the relative importance of non-HDL-C levels at specific life stages for CAC remains unclear. Objective: To identify the relative association of non-HDL-C measured at distinct life stages (adolescence, young adulthood, mid-adulthood) with the presence of CAC measured in mid-adulthood. Design, Setting, and Participants: The Cardiovascular Risk in Young Finns Study is a population-based prospective cohort study that started in 1980 with follow-up over 28 years. Participants from 3 population centers (Kuopio, Tampere, and Turku in Finland) represent a convenience sample drawn from the 3 oldest cohorts at baseline (aged 12-18 years in 1980). Data were collected from September 1980 to August 2008. Analysis began February 2020. Exposures: Non-HDL-C levels were measured at 3 life stages including adolescence (aged 12-18 years), young adulthood (aged 21-30 years), and mid-adulthood (aged 33-45 years). Main Outcomes and Measures: In 2008, CAC was determined from computed tomography and dichotomized as 0 (no CAC, Agatston score = 0) and 1 (presence of CAC, Agatston score ≥1) for analysis. Using a bayesian relevant life course exposure model, the relative association was determined between non-HDL-C at each life stage and the presence of CAC in mid-adulthood. Results: Of 589 participants, 327 (56%) were female. In a model adjusted for year of birth, sex, body mass index, systolic blood pressure, blood glucose level, smoking status, lipid-lowering and antihypertensive medication use, and family history of heart disease, cumulative exposure to non-HDL-C across all life stages was associated with CAC (odds ratio [OR], 1.50; 95% credible interval [CrI], 1.14-1.92). At each life stage, non-HDL-C was associated with CAC and exposure to non-HDL-C during adolescence had the strongest association (adolescence: OR, 1.16; 95% CrI, 1.01-1.46; young adulthood: OR, 1.14; 95% CrI, 1.01-1.43; mid-adulthood: OR, 1.12; 95% CrI, 1.01-1.34). Conclusions and Relevance: These data suggest that elevated non-HDL-C levels at all life stages are associated with coronary atherosclerosis in mid-adulthood. However, adolescent non-HDL-C levels showed the strongest association with the presence of CAC in mid-adulthood, and greater awareness of the importance of elevated non-HDL-C in adolescence is needed.
Importance: Elevated non-high-density lipoprotein cholesterol (non-HDL-C) is associated with the presence of coronary artery calcification (CAC), a marker of heart disease in adulthood. However, the relative importance of non-HDL-C levels at specific life stages for CAC remains unclear. Objective: To identify the relative association of non-HDL-C measured at distinct life stages (adolescence, young adulthood, mid-adulthood) with the presence of CAC measured in mid-adulthood. Design, Setting, and Participants: The Cardiovascular Risk in Young Finns Study is a population-based prospective cohort study that started in 1980 with follow-up over 28 years. Participants from 3 population centers (Kuopio, Tampere, and Turku in Finland) represent a convenience sample drawn from the 3 oldest cohorts at baseline (aged 12-18 years in 1980). Data were collected from September 1980 to August 2008. Analysis began February 2020. Exposures: Non-HDL-C levels were measured at 3 life stages including adolescence (aged 12-18 years), young adulthood (aged 21-30 years), and mid-adulthood (aged 33-45 years). Main Outcomes and Measures: In 2008, CAC was determined from computed tomography and dichotomized as 0 (no CAC, Agatston score = 0) and 1 (presence of CAC, Agatston score ≥1) for analysis. Using a bayesian relevant life course exposure model, the relative association was determined between non-HDL-C at each life stage and the presence of CAC in mid-adulthood. Results: Of 589 participants, 327 (56%) were female. In a model adjusted for year of birth, sex, body mass index, systolic blood pressure, blood glucose level, smoking status, lipid-lowering and antihypertensive medication use, and family history of heart disease, cumulative exposure to non-HDL-C across all life stages was associated with CAC (odds ratio [OR], 1.50; 95% credible interval [CrI], 1.14-1.92). At each life stage, non-HDL-C was associated with CAC and exposure to non-HDL-C during adolescence had the strongest association (adolescence: OR, 1.16; 95% CrI, 1.01-1.46; young adulthood: OR, 1.14; 95% CrI, 1.01-1.43; mid-adulthood: OR, 1.12; 95% CrI, 1.01-1.34). Conclusions and Relevance: These data suggest that elevated non-HDL-C levels at all life stages are associated with coronary atherosclerosis in mid-adulthood. However, adolescent non-HDL-C levels showed the strongest association with the presence of CAC in mid-adulthood, and greater awareness of the importance of elevated non-HDL-C in adolescence is needed.
Authors: Joel Nuotio; Mervi Oikonen; Costan G Magnussen; Jorma S A Viikari; Nina Hutri-Kähönen; Antti Jula; Russell Thomson; Matthew A Sabin; Stephen R Daniels; Olli T Raitakari; Markus Juonala Journal: Atherosclerosis Date: 2015-02-07 Impact factor: 5.162
Authors: Olli Hartiala; Costan G Magnussen; Sami Kajander; Juhani Knuuti; Heikki Ukkonen; Antti Saraste; Irina Rinta-Kiikka; Sakari Kainulainen; Mika Kähönen; Nina Hutri-Kähönen; Tomi Laitinen; Terho Lehtimäki; Jorma S A Viikari; Jaakko Hartiala; Markus Juonala; Olli T Raitakari Journal: J Am Coll Cardiol Date: 2012-09-12 Impact factor: 24.094
Authors: Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Michael LeFevre; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu Journal: JAMA Date: 2016-08-09 Impact factor: 56.272
Authors: Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen Journal: Eur Heart J Date: 2013-08-15 Impact factor: 29.983
Authors: Aino-Maija Eloranta; Taisa Sallinen; Anna Viitasalo; Niina Lintu; Juuso Väistö; Henna Jalkanen; Tuomo T Tompuri; Sonja Soininen; Eero A Haapala; Sanna Kiiskinen; Theresia M Schnurr; Tuomas O Kilpeläinen; Santtu Mikkonen; Kai Savonen; Mustafa Atalay; Soren Brage; David E Laaksonen; Virpi Lindi; Jyrki Ågren; Ursula Schwab; Jarmo Jääskeläinen; Timo A Lakka Journal: Eur J Nutr Date: 2020-05-04 Impact factor: 5.614
Authors: Yaxing Meng; Marie-Jeanne Buscot; Markus Juonala; Feitong Wu; Matthew K Armstrong; Brooklyn J Fraser; Katja Pahkala; Nina Hutri-Kähönen; Mika Kähönen; Tomi Laitinen; Jorma S A Viikari; Olli T Raitakari; Costan G Magnussen; James E Sharman Journal: J Am Heart Assoc Date: 2022-06-14 Impact factor: 6.106
Authors: Omar Dzaye; Alexander C Razavi; Zeina A Dardari; Leslee J Shaw; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Khurram Nasir; Alan Rozanski; John A Rumberger; Carl E Orringer; Sidney C Smith; Ron Blankstein; Seamus P Whelton; Martin Bødtker Mortensen; Michael J Blaha Journal: J Am Coll Cardiol Date: 2021-10-19 Impact factor: 27.203
Authors: Xiwen Ji; Zicheng Zhang; Dan Lin; Mali Dai; Xia Zhao; Xingneng Guo; Jie Du; Meng Zhou; Yuqin Wang Journal: Transl Vis Sci Technol Date: 2021-11-01 Impact factor: 3.283